Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001415889-25-000152

PRESIDENT AND CEO gave up 24,536 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · PRESIDENT AND CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-31 Shares withheld for taxes : show line 1 in the form −24,536 $3.35 $82,196 476,061 D
Loading xslF345X05/form4-01022025_050101.xml…